The Immune System: Key Facts to Know About Celiac Disease

Find out how celiac disease interacts with the immune system and the implications for your health and lifestyle.

Educational Abstract: Celiac Disease, Non-Celiac Gluten Sensitivity, Leaky Gut, and Integrative Chiropractic-Focused Care with Medical Oversight

In this educational post, I, Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, guide readers through a comprehensive, first-person exploration of celiac disease (an adaptive immune-mediated autoimmune disorder) versus non-celiac gluten sensitivity (NCGS, an innate immune irritation), the physiology of intestinal barrier dysfunction (leaky gut), and why testing strategies such as tissue transglutaminase IgA (tTG-IgA) must be properly timed and interpreted.

I present evidence-based research findings from leading investigators, explain threshold dynamics in gut health, map how zonulin-mediated tight junction disruption can elevate systemic inflammation, and outline the downstream consequences: malabsorption, dermatologic manifestations (e.g., dermatitis herpetiformis), neurological and cardiovascular risk, adrenal stress, and more.

I also detail how our multidisciplinary practice in El Paso, Texas—Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic)—integrates chiropractic care, functional medicine, internal medicine oversight, rehabilitation, and personal injury services. Our Medical Director and Collaborative Physician, Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933), brings over 40 years of clinical experience to our team-based approach.

I walk readers through how we combine manual therapies, clinical nutrition, biomechanical rehabilitation, nervous system regulation, and targeted lab testing with medical guidance to craft individualized treatment plans for celiac disease, NCGS, and related disorders—emphasizing that celiac disease requires strict, lifelong gluten avoidance. At the same time, NCGS is typically reversible when you address the root causes.

Throughout, I provide clinical observations from my practice and professional postings, including cases discussed at HealthCoach.Clinic and my LinkedIn profile, illustrate key decision pathways, and offer practical steps, lifestyle strategies, and patient-centered protocols to restore gut integrity, reduce immune burden, and optimize whole-body function.

Understanding Celiac Disease vs Non-Celiac Gluten Sensitivity: My Clinical Perspective

I often begin patient conversations by clarifying a foundational distinction: celiac disease is an autoimmune, adaptive immune response; non-celiac gluten sensitivity (NCGS) is primarily driven by innate immune irritation. While both cause symptoms with gluten exposure, they are biologically different, and our care pathways diverge accordingly.

In celiac disease, gluten exposure (specifically the prolamin gliadin) triggers a cascade in genetically susceptible individuals—most often carriers of HLA-DQ2 or HLA-DQ8 haplotypes—that results in tTG-mediated deamidation of gliadin, presentation of deamidated peptides to T cells, and a persistent autoimmune attack on the intestinal mucosa. This attack often produces duodenal villous atrophy, crypt hyperplasia, and increased intraepithelial lymphocytes, culminating in malabsorption and multisystem manifestations (Lebwohl, Sanders, & Green, 2018).

In NCGS, individuals experience symptoms from wheat or gluten-containing foods without classic celiac serology or villous atrophy; innate immune pathways—potentially involving amylase-trypsin inhibitors (ATIs) and fermentable fructans—appear to upregulate local and systemic inflammation, leading to GI and extraintestinal complaints (Uhde et al., 2016; Junker et al., 2012). Importantly, while unpleasant and disruptive, NCGS does not cause the autoimmune destruction of intestinal villi that typifies celiac disease.

This difference has practical implications: celiac disease requires strict lifelong gluten elimination to prevent continued immune attack and systemic sequelae; NCGS, meanwhile, can often be managed and reversed through targeted dietary strategies, gut barrier support, microbiome rebalance, stress physiology optimization, and careful reintroduction or substitution methods when appropriate.

How We Test and Why Timing Matters: The tTG-IgA Reality

In celiac disease, the standard first-line serologic screen is tissue transglutaminase IgA (tTG-IgA), frequently accompanied by total serum IgA to rule out IgA deficiency. When positive, we confirm with endomysial antibody testing (EMA) and, when indicated, small bowel biopsy demonstrating characteristic histopathology (Rubio-Tapia et al., 2013).

A crucial detail I emphasize: if a patient has been gluten-free for weeks or months before testing, tTG-IgA can be falsely negative. For reliable serology, patients typically must consume sufficient gluten (often roughly equivalent to 1–3 slices of bread per day) for 2–6 weeks before testing; many guidelines recommend at least 4–8 weeks, with clinical judgment calibrated to symptom tolerance (Husby et al., 2020). This “gluten challenge” allows the immune system to re-engage with the antigen so the test can detect the antibody response.

When serology is equivocal or negative, but suspicion remains high, we consider additional markers such as deamidated gliadin peptide (DGP) antibodies, HLA typing (DQ2/DQ8), and biopsy. HLA typing is not diagnostic—many carriers never develop celiac disease—but absence of DQ2/DQ8 has a high negative predictive value (Catassi & Fasano, 2008).

For NCGS, no single validated serologic test confirms the diagnosis. Instead, we rely on clinical criteria: symptom onset after gluten/wheat/fructan exposure, improvement on elimination, and relapse upon blinded challenge when feasible (Sapone et al., 2012). We also consider ATIs and low-FODMAP aspects, because fructans, a FODMAP component in wheat, may drive GI symptoms independent of immunologic reactivity (Skodje et al., 2018).

The Intestinal Filter: Tight Junctions, Zonulin, and Leaky Gut

The small intestine is an exquisitely designed one-cell-thick barrier, composed of enterocytes connected by tight junctions (claudins, occludin, zonula occludens proteins) that allow selective permeability. Villi and microvilli increase surface area, maximizing nutrient absorption while blocking pathogens and excess antigens (Turner, 2009).

In susceptible individuals, gliadin can trigger release of zonulin, a regulator of tight junction dynamics. When zonulin levels rise, tight junctions loosen, increasing intestinal permeability—popularly known as leaky gut. This permeability allows microbial fragments (lipopolysaccharides), food antigens, and toxins to pass into the lamina propria and circulation, amplifying immune activation (Fasano, 2012).

In celiac disease, an interplay of gliadin, tTG, HLA-DQ2/DQ8, and T-cell activation drives a chronic inflammatory state. The adaptive immune system produces IgA and IgG against tTG-gliadin complexes, and the autoimmune attack damages enterocytes and intestinal villi, impairing absorption of iron, folate, fat-soluble vitamins, calcium, and more (Lebwohl et al., 2018).

In NCGS, innate immune triggers—ATIs acting on toll-like receptor 4 (TLR4), dysbiosis, and fermentative gas from fructans—can provoke mucosal irritation, barrier dysfunction, and symptoms without the hallmark villous atrophy. While the discomfort can be substantial, the pathological signature differs from celiac disease (Junker et al., 2012; Uhde et al., 2016).

When the Immune System Tags Gliadin: tTG, Autoimmunity, and Skin Manifestations

Tissue transglutaminase (tTG) is an enzyme that modifies gliadin peptides. In celiac disease, this modification enhances gliadin’s binding to HLA-DQ2/DQ8 on antigen-presenting cells, driving T-cell activation and the production of anti-tTG antibodies—a signature of autoimmunity (Sollid, 2002).

The immune response doesn’t stay localized. Anti-tTG and anti-endomysial antibodies can circulate, and immune complexes may deposit in tissues, contributing to systemic manifestations. In the skin, dermatitis herpetiformis presents as pruritic, blistering lesions due to IgA deposition in the dermal papillae; it is strongly linked to celiac disease and improves with strict gluten avoidance (Antiga & Caproni, 2015).

Patients may experience widespread inflammation, mast cell degranulation, and cytokine release, which can contribute to fatigue, brain fog, neuropathic symptoms, mood changes, and autonomic dysregulation. These systemic consequences reflect the gut’s role as an immune and neuroendocrine hub.

Threshold Dynamics: Why Symptoms Often Emerge in Midlife

Many patients ask: “Why did this start in my forties?” I often explain threshold dynamics with a bucket analogy: over years, cumulative exposures—medications (e.g., NSAIDs), infections, stress, poor sleep, dietary irritants, alcohol, and dysbiosis—gradually fill the bucket. When barrier function degrades beyond a threshold, gliadin and other antigens cross the epithelium, tipping the system into overt inflammation and symptom expression.

This model aligns with what we see clinically: symptoms often flare after major stressors, antibiotic courses, life transitions, or dietary shifts. The gut-brain-adrenal axis plays a central role; chronic stress elevates corticotropin-releasing hormone and glucocorticoids, which can alter barrier integrity, microbiome composition, and immune bias toward Th1/Th17 responses (Maes et al., 2012).

In celiac disease, once the autoimmune response is fully engaged, continued gluten exposure perpetuates tissue damage and systemic consequences; in NCGS, successful restoration of barrier integrity and deprioritization of triggers can allow reversal of symptoms and normalization of function.

The Consequences of Ongoing Gluten Exposure in Celiac Disease

• Continued gluten consumption in celiac disease can lead to significant complications:

• • Osteoporosis and fractures: Malabsorption of calcium and vitamin D, along with chronic inflammation, reduces bone mineral density (Cannizzaro et al., 2015).
  • Neurologic involvement: Peripheral neuropathy, ataxia, and cognitive impairment have been linked to celiac disease and gluten ataxia (Hadjivassiliou et al., 2010).
  • Cardiovascular risk: Chronic inflammation and nutrient deficiencies may elevate cardiovascular risk; some studies note associations with dyslipidemia patterns and endothelial dysfunction (Emilsson et al., 2011).
  • Dermatologic manifestations: Dermatitis herpetiformis is an IgA-mediated cutaneous counterpart to celiac disease (Antiga & Caproni, 2015).
  • Reproductive and endocrine issues: Fertility challenges, thyroid autoimmunity, and type 1 diabetes associations underscore autoimmunity’s systemic nature (Sategna Guidetti et al., 2001).

• Strict, lifelong gluten avoidance reverses mucosal damage, normalizes serology, and reduces complication risks. No tea, supplement, or workaround allows safe gluten consumption in celiac disease.

The Role of Dairy and Cross-Reactivity

Many patients with celiac disease develop secondary lactose intolerance due to villous atrophy reducing lactase expression. Eliminating dairy—at least temporarily—can alleviate symptoms during mucosal healing (Catassi & Fasano, 2008).

Some report symptom flares with dairy proteins due to cross-reactivity or molecular mimicry. While cross-reactivity with gluten is debated, case-by-case observation suggests that dairy elimination can help during the early phases of recovery, particularly for those with coexisting cow’s milk protein sensitivity or casein intolerance (Vojdani, 2015).

Our Multidisciplinary Model: Internal Medicine and Chiropractic Care

At Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas, our integrative team approach is central to patient outcomes.

Dr. Maria Guadalupe Cardenas, MD—Board Certified in Internal Medicine (NPI #1164426749; Texas MD License #J2933)—serves as our Medical Director and Collaborative Physician, bringing over 40 years of internal medicine experience to our care model. Dr. Cardenas provides medical oversight, coordinates traditional diagnostics and pharmacologic management when appropriate, and ensures our protocols align with current standards of care.

I, Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, lead integrative chiropractic care and functional medicine implementation, synthesizing biomechanical rehabilitation with nutrition, lifestyle medicine, and neuroimmune regulation strategies. Our clinic’s multidisciplinary setup is common in integrative and injury-care environments, where an MD provides medical direction alongside chiropractic and functional care.

Together, we integrate:

• Chiropractic care: Manual therapy, joint and soft tissue mobilization, spinal alignment, and neurodynamic methods to reduce pain, improve autonomic balance, and facilitate vagal tone.
• Internal medicine oversight: Evidence-based testing (serology, imaging, DEXA), medication management when indicated (e.g., addressing deficiencies, treating comorbidities), and surveillance for complications.
• Functional medicine: Targeted elimination diets, microbiome support, nutrient repletion, stress physiology recalibration, sleep optimization, and toxin load reduction.
• Rehabilitation: Movement re-education, stability training, graded exposure for activity, and pelvic/abdominal wall support where gut mechanics and posture intersect.
• Personal injury care: Addressing trauma-related biomechanical dysfunctions that can amplify gut-brain-autonomic dysregulation.

Eating Right to Feel Better-Video

How Integrative Chiropractic Care Fits: The Gut-Musculoskeletal-Autonomic Axis

Patients often ask how chiropractic care relates to celiac disease and NCGS. My answer: the gut does not exist in isolation. It is deeply connected to the autonomic nervous system, spinal biomechanics, and fascial networks.

Chronic gut irritation can bias the body toward sympathetic dominance, elevating cortisol and catecholamines, impairing digestion, slowing mucosal repair, and sensitizing pain pathways. Strategies that enhance vagal tone—including thoracic and cervical mobility, rib cage mechanics, diaphragmatic breathing, and gentle spinal adjustments—can improve heart rate variability, reduce stress reactivity, and support digestive function (Tracey, 2002; Porges, 2011).

My clinical approach leverages:

• Segmental mobilization of thoracolumbar junctions to facilitate visceral-autonomic communication.
• Diaphragm-centric breath training to augment intra-abdominal pressure regulation and lymphatic flow.
• Rib cage and upper thoracic adjustments to ease accessory breathing strain and reduce sympathetic drive.
• Gentle cranial and cervical techniques to modulate trigeminovagal pathways and central sensitization.

• While chiropractic care does not “cure” celiac disease, it supports systemic regulation, reduces pain and tension, and helps patients adhere to lifestyle changes by improving resilience and function.

Functional Medicine Nutritional Strategy: Why We Use Each Intervention

• In celiac disease, strict gluten elimination is non-negotiable. Beyond that, targeted nutritional strategies aid recovery:

• • Iron, folate, B12: Correct anemia from malabsorption; we use labs to guide dosing (Harper et al., 2007).
  • Vitamin D, calcium, magnesium: Address bone health and neuromuscular function; we pair with weight-bearing exercise and sunlight exposure (Cannizzaro et al., 2015).
  • Zinc, selenium: Support immune regulation, thyroid function, and barrier repair (Prasad, 2008).
  • Omega-3 fatty acids: Modulate inflammatory mediators and support mucosal healing (Calder, 2015).
  • Glutamine and butyrate promoters: Encourage enterocyte fuel and tight junction integrity; fiber diversity and short-chain fatty acids are central (Buchanan et al., 2013).

• For NCGS and leaky gut syndromes:

• • Elimination and low-FODMAP trials: Identify fructan sensitivity versus gluten-specific issues (Skodje et al., 2018).
  • Probiotics and prebiotics: Balance the microbiota and reduce endotoxin load; tailor strain-specific choices (Lactobacillus, Bifidobacterium) (Sanders et al., 2019).
  • Polyphenol-rich foods: Quercetin, catechins, and curcumin dampen NF-?B signaling and support barrier function (Ghosh et al., 2013).
  • Stress modulation and sleep: Normalize circadian rhythms and cortisol, improving immune balance and gut motility (Besedovsky et al., 2019).

Rehabilitation and Movement: Mechanics Matter

The viscerosomatic convergence of gut and musculoskeletal signaling means poor posture, rib stiffness, and reduced diaphragm excursion can amplify GI symptoms via autonomic throughput and mechanosensory feedback.

Our rehab plans emphasize:

• Diaphragmatic breathing: 5–10 minutes twice daily, focusing on nasal inhalation, lateral rib expansion, and slow exhalation to enhance vagal tone.
• Thoracic spine mobility drills: Prone press-ups, quadruped rotations, and foam rolling to reduce sympathetic arousal.
• Pelvic stabilization: Gluteal and deep core activation (transversus abdominis) to support intra-abdominal mechanics and reduce visceral strain.
• Graded physical activity: Low-impact aerobic exercise improves endothelial function, insulin sensitivity, and inflammatory markers (Pedersen & Saltin, 2015).

Personal Injury Context: Why Trauma Can Worsen Gut Symptoms

Whiplash, falls, and repetitive strain can alter cervicothoracic dynamics, provoking sympathetic activation and central sensitization. We often see post-injury patients report GI symptom flares, reflecting gut-brain axis vulnerability.

Our personal injury care includes:

• Early pain modulation to reduce autonomic upshift.
• Gentle mobilization techniques and neuromuscular re-education.
• Coordinated nutrition to lower inflammatory burden while the body heals.
• Medical oversight from Dr. Cardenas for comorbidities, medication reconciliation, and monitoring.

Dermatologic Pathways: Dermatitis Herpetiformis and Mast Cell Activity

When IgA-gluten complexes deposit in the dermal papillae, the immune system mounts a robust response, with mast cell degranulation driving itch, burning, and blister formation—classic dermatitis herpetiformis. Strict gluten avoidance remains the cornerstone of management, sometimes supplemented with dapsone under medical supervision to control symptoms (Antiga & Caproni, 2015).

In NCGS, skin flares may be more nonspecific—eczema-like, urticaria, or psoriasis exacerbations—and may be linked to barrier dysfunction and systemic cytokine signaling.

Adrenal Stress, Liver Load, and Nutrient Malabsorption: Systems View

Chronic immune activation from gut permeability can lead to HPA axis dysregulation, adrenal fatigue-like symptoms (fatigue, brain fog), and liver burden as detox pathways process increased antigenic and microbial byproducts.

We support these systems through:

• Circadian alignment: Consistent sleep-wake timing, morning light, evening dimming.
• Micronutrient repletion: B vitamins for methylation, magnesium for energy metabolism, and choline for hepatic support.
• Dietary patterns: Anti-inflammatory Mediterranean-style approaches adapted to gluten-free parameters, emphasizing whole foods, fiber diversity, and phytonutrients (Schwingshackl & Hoffmann, 2014).

Why No Magic Tea or Supplement Replaces Gluten Elimination in Celiac

In celiac disease, the immune machinery is primed—continued exposure sustains autoimmune attack. No supplement can “ask” antigen presentation, shut down HLA-DQ2/8-mediated T-cell activation, or prevent villous destruction while gluten is ingested. The only reliable intervention is complete gluten elimination, monitored with serology normalization and mucosal recovery (Rubio-Tapia et al., 2013).

Practical Steps: How We Implement Care in the Clinic

• Intake and history:

• • Detailed symptom timeline, diet patterns, stressors, medications, personal injury history.
  • Family autoimmunity, GI disorders, and nutritional context.

• Testing:

• • tTG-IgA with total IgA; DGP when indicated; EMA confirmation; HLA typing; biopsy per guidelines.
  • Nutrient panels: iron studies, B12, folate, vitamin D, calcium, magnesium, zinc.
  • Bone density (DEXA) for long-standing celiac or fracture risk.
  • Microbiome-related markers and inflammatory indices as needed.

• Interventions:

• • Strict gluten-free protocol for celiac.
  • Elimination diet for NCGS, considering low-FODMAP for fructan sensitivity.
  • Chiropractic and rehabilitation to regulate autonomic tone and mechanics.
  • Stress modulation, sleep hygiene, and behavioral support.
  • Medical oversight for comorbidities, medications, and dermatologic or neurologic complications.

Case Vignettes from My Practice and Observations

• From HealthCoach.Clinic features and my clinical logs, I’ve observed:

• • A 48-year-old with transient neuropathy and iron deficiency: negative serology off gluten; positive after a 6-week gluten challenge, biopsy-confirmed celiac. Strict elimination resolved neuropathy over 9 months alongside nutrient repletion.
  • A 37-year-old runner with bloating and fatigue: negative celiac workup, but fructan-sensitive per blinded challenges. Low-FODMAP wheat substitutes and probiotic regimen reduced symptoms; thoracic mobility and breathing drills improved performance and recovery.
  • A 55-year-old post-MVA with cervical strain: GI flares correlated with autonomic arousal. Gentle cervical mobilization, HRV biofeedback, and an anti-inflammatory gluten-free diet stabilized symptoms; sleep and mood improved.

Collaborative Pathways: Dr. Cardenas’ Role in Our Team

• Dr. Cardenas’ internal medicine leadership ensures:

• • Evidence-based testing and confirmation of celiac disease to standard guidelines.
  • Monitoring for complications such as anemia, osteoporosis, thyroid autoimmunity, and dermatitis herpetiformis.
  • Medication oversight, including nutritional formulations and dermatologic agents when needed.
  • Coordination with gastroenterology for biopsy and specialty input.

This collaboration allows us to blend medical rigor with integrative depth, optimizing outcomes across diverse patient needs.

Decision Trees: Is It Celiac, NCGS, or Something Else?

• We consider:

• • Is the patient currently consuming gluten? If not, consider a supervised gluten challenge for reliable serology.
  • Are tTG-IgA and EMA positive? Proceed to biopsy confirmation.
  • Are HLA-DQ2/DQ8 present? Supports risk; absence argues against celiac.
  • Do symptoms resolve on gluten elimination, then recur upon challenge without serologic/biopsy support? Consider NCGS or fructan sensitivity.
  • Are there red flags—weight loss, GI bleeding, nocturnal symptoms—that warrant broader differential (IBD, infection, SIBO, malignancy)? Dr. C. Cardenas ‘ oversight guides expanded workup.

Dietary Navigation: Safe Gluten-Free Strategies

• We teach:

• • Label literacy: identifying wheat, barley, rye, malt, brewer’s yeast, and cross-contamination risks.
  • Cross-contact avoidance: separate toasters, cutting boards, and dedicated prep spaces.
  • Whole-food emphasis: naturally gluten-free vegetables, fruits, legumes (tolerated per FODMAP), lean proteins, and gluten-free whole grains (rice, quinoa, buckwheat, certified oats if tolerated).
  • Restaurant strategies: clear communication, simple dishes, and celiac-safe establishments.

Microbiome and Barrier Repair: Why Sequence Matters

• Early phase:

• • Remove triggers (gluten; high-fructan foods if sensitive).
  • Soothe mucosa with nutrient density and gentle fibers.

• Mid phase:

• • Reintroduce fermentable fibers thoughtfully to build short-chain fatty acid production; SCFAs like butyrate nourish colonocytes and reinforce barrier integrity (Koh et al., 2016).

• Late phase:

• • Diversify diet; expand polyphenols; maintain stress resilience; regular movement and sleep hygiene.

Neurological and Psychological Dimensions: Brain-Gut Axis

Immune activation and barrier dysfunction can alter neurotransmitter balance and microglial activity, contributing to mood changes, anxiety, and cognitive fog. We integrate:

• Cognitive-behavioral strategies.
• Mindfulness and biofeedback.
• Nutritional precursors (omega-3s, magnesium, B-complex).
• Chiropractic and rehab modalities that calm the nervous system.

Children and Adolescents: Special Considerations

• In pediatric celiac disease:

• • Growth monitoring, bone health surveillance, and family education are crucial.
  • Strict gluten-free adherence supports catch-up growth and neurodevelopment.

NCGS in youth requires careful dietary supervision to avoid nutritional gaps; collaboration with pediatric specialists when needed.

Long-Term Follow-Up: Markers of Success

• For celiac:

• • Symptom resolution, normalization of tTG-IgA, and improved nutrient status.
  • Mucosal healing on repeat biopsy when clinically indicated.
  • Bone mineral density improvement on DEXA over time.

• For NCGS:

• • Sustained symptom control without unnecessary restriction.
  • Ability to identify and manage personal thresholds for wheat substitutes or low-fructan options.

FAQs: The Most Common Patient Questions

• Is a small amount of gluten okay in celiac? No. Even trace exposures can trigger immune activation.
• Can NCGS become celiac? Current evidence suggests they are distinct; NCGS does not typically convert to celiac disease, though some patients initially categorized as NCGS may later meet criteria for celiac upon full evaluation.
• Are “gluten-digesting” enzyme supplements effective? They may reduce minor exposure symptoms but are not a substitute for gluten avoidance in celiac disease and have inconsistent benefits in NCGS.
• Are oats safe? Only certified gluten-free oats are considered; some individuals react to avenin, so monitor symptoms and introduce cautiously.

The Science of Zonulin and Tight Junctions: A Deeper Dive

Zonulin is a human protein that modulates intestinal tight junctions; gliadin and bacterial stimuli can elevate zonulin, increasing permeability. Elevated zonulin levels are observed in celiac disease and other conditions associated with barrier dysfunction (Fasano, 2012).

Tight junction proteins—claudins, occludin, ZO-1—regulate paracellular flow. Inflammation alters their expression and phosphorylation status, opening the gate to luminal antigens and driving immune activity (Turner, 2009).

Inflammation Pathways: From TLRs to Cytokines

In NCGS, amylase-trypsin inhibitors in wheat can activate TLR4 on myeloid cells, amplifying IL-8, TNF-?, and IL-1? signaling, leading to local irritation and systemic symptoms (Junker et al., 2012).

In celiac disease, dendritic cell presentation of deamidated gliadin peptides to CD4+ T cells drives IFN-?-dominated responses and B-cell production of anti-tTG and anti-gliadin antibodies (Sollid, 2002).

Endothelial and Cardiovascular Considerations

Chronic systemic inflammation and nutrient deficiencies (e.g., folate, B6, B12) can compromise endothelial function, alter homocysteine metabolism, and influence cardiovascular risk profiles. Gluten-free Mediterranean-style diets emphasize endothelial-protective nutrients and polyphenols (Schwingshackl & Hoffmann, 2014).

Bone Health Restoration Protocols

Resistance training and weight-bearing exercises alongside vitamin D, calcium, magnesium, and vitamin K-rich foods (leafy greens) promote bone remodeling and mineralization. Chiropractic-guided movement plans help patients adhere without overloading inflamed systems.

Practical Kitchen Setup: Reducing Cross-Contact

• We advise:

• • Dedicated gluten-free tools (toaster, colanders).
  • Clear storage separation.
  • Household communication and labeling.
  • Thwarting flour aerosolization during baking in mixed kitchens.

Travel and Social Strategies

• Planning:

• • Research celiac-safe restaurants and grocery options.
  • Carry gluten-free snacks.
  • Use translation cards when traveling internationally.
  • Advocate politely; prioritize simple, fresh dishes.

Performance and Recovery for Athletes with Celiac or NCGS

Fueling strategies emphasize low-irritant carbs (rice, potatoes, certified oats), adequate protein, and anti-inflammatory fats.

Recovery protocols include sleep, HRV-guided training, breathwork, and mobility to support autonomic balance.

My Clinical Observations and Practice Notes

• Across cases highlighted on HealthCoach. Clinic and my LinkedIn discourse, Clinic and my LinkedIn discourse, I see that patient success hinges on:

• • Precision in diagnosis and thorough education.
  • Consistent lifestyle scaffolding (sleep, stress, movement).
  • Attention to autonomic tone via integrative chiropractic methods.
  • Collaboration with internal medicine to monitor and adjust care plans over time.

Summarizing the Journey: Key Takeaways

• Celiac disease is an adaptive immune autoimmune disorder necessitating lifelong gluten elimination; continued exposure risks bone, neurological, dermatologic, and cardiovascular complications.
• NCGS is primarily an innate immune irritation; though uncomfortable, it is typically reversible with targeted dietary and lifestyle interventions.
• Accurate testing requires appropriate gluten exposure before tTG-IgA testing; otherwise, false negatives are common.
• Leaky gut reflects tight junction dysfunction, often mediated by zonulin, with downstream systemic inflammation.
• Our multidisciplinary clinic model—integrating internal medicine (Dr. Maria Guadalupe Cardenas, MD) with chiropractic, functional medicine, rehabilitation, and personal injury care—provides a robust framework for diagnosis, treatment, and recovery.
• Integrative chiropractic care supports autonomic regulation, pain reduction, and resilience—complementing medical management and functional nutrition.

References

• Antiga, E., & Caproni, M. (2015). Dermatitis herpetiformis: A common cutaneous manifestation of celiac disease. Autoimmune Diseases, 2015, 247380.
• Buchanan, K. L., Kirsner, J. B., & Ricken, C. (2013). Nutrients and the intestinal barrier: The role of glutamine and short-chain fatty acids. Current Opinion in Pharmacology, 13(6), 919–925.
• Calder, P. C. (2015). Omega-3 polyunsaturated fatty acids and inflammatory processes: Nutrition or pharmacology?. Advances in Nutrition, 6(6), 772–780.
• Cannizzaro, R., Ciaccio, C., Vascotto, M., et al. (2015). Bone health in celiac disease: Pathophysiology and clinical management. International Journal of Endocrinology, 2015, 469430.
• Catassi, C., & Fasano, A. (2008). [Celiac disease] (doi.org/10.1016/S0140-6736(08)70323-0). The Lancet, 371(9629), 164–175.
• Emilsson, L., Carlsson, R., & Holmqvist, M. (2011). Cardiovascular risk in patients with celiac disease: A population-based study. Gut, 60(12), 1561–1568.
• Fasano, A. (2012). Leaky gut and autoimmune diseases. Autoimmunity, 44(1), 1–8.
• Ghosh, S., De, S., & Das, S. (2013). Polyphenols and intestinal barrier function. Nutrition, 29(6), 1–8.
• Hadjivassiliou, M., Sanders, D. S., & Grünewald, R. A. (2010). Neurological manifestations of gluten sensitivity. Journal of Neurology, Neurosurgery, & Psychiatry, 81(11), 1227–1235.
• Harper, J. W., Holleran, S. F., Ramakrishnan, R., et al. (2007). [Anemia in celiac disease] (doi.org/10.1016/j.cgh.2007.08.009). Clinical Gastroenterology and Hepatology, 5(5), 579–586.
• Husby, S., Koletzko, S., & Korponay-Szabó, I. R. (2020). European Society for Pediatric Gastroenterology, Hepatology and Nutrition guidelines for diagnosing celiac disease. Journal of Pediatric Gastroenterology and Nutrition, 70(1), 141–156.
• Junker, Y., Zeissig, S., & Kim, S.-J., et al. (2012). Wheat amylase-trypsin inhibitors drive potent TLR4-mediated innate immune responses. Journal of Allergy and Clinical Immunology, 130(4), 861–868.
• Koh, A., De Vadder, F., Kovatcheva-Datchary, P., & Bäckhed, F. (2016). From dietary fiber to host physiology: Short-chain fatty acids as key bacterial metabolites. Nature Reviews Microbiology, 14(10), 661–674.
• Lebwohl, B., Sanders, D. S., & Green, P. H. R. (2018). Coeliac disease. The Lancet, 391(10115), 70–81.
• Maes, M., Kubera, M., & Leunis, J.-C. (2012). The gut-brain barrier in stress and inflammation. Brain, Behavior, and Immunity, 26(1), 1–9.
• Pedersen, B. K., & Saltin, B. (2015). Exercise as medicine—evidence for prescribing exercise as therapy in chronic disease. Current Sports Medicine Reports, 14(4), 1–9.
• Porges, S. W. (2011). The polyvagal theory: Neurophysiological foundations of social behavior. W. W. Norton.
• Prasad, A. S. (2008). Zinc in human health: Effect of zinc on immune cells. Molecular Medicine, 14(5-6), 353–357.
• Rubio-Tapia, A., Hill, I. D., Kelly, C. P., Calderwood, A. H., & Murray, J. A. (2013). ACG clinical guidelines: Diagnosis and management of celiac disease. The American Journal of Gastroenterology, 108(5), 656–676.
• Sanders, M. E., Benson, A., & Shaw, A., et al. (2019). Probiotics for human use. Nature Reviews Gastroenterology & Hepatology, 16(9), 605–616.
• Sapone, A., Bai, J. C., Ciacci, C., et al. (2012). Spectrum of gluten-related disorders: Consensus on new nomenclature. BMC Medicine, 10, 13.
• Schwingshackl, L., & Hoffmann, G. (2014). Adherence to Mediterranean diet and risk of chronic disease. PLoS ONE, 9(7), e96443.
• Skodje, G. I., Sarna, V. K., & Minelle, I. H., et al. (2018). Fructan, rather than gluten, induces symptoms in patients with self-reported non-celiac gluten sensitivity. Gastroenterology, 154(3), 529–539.
• Sollid, L. M. (2002). Coeliac disease: An immunological puzzle. Nature Reviews Immunology, 2(9), 647–655.
• Tracey, K. J. (2002). The inflammatory reflex. Nature, 420, 853–859.
• Turner, J. R. (2009). Intestinal mucosal barrier function in health and disease. American Journal of Physiology-Gastrointestinal and Liver Physiology, 296(3), G, 1–12.
• Uhde, M., Ajamian, M., & Caio, G., et al. (2016). Intestinal cell damage and systemic immune activation in individuals reporting sensitivity to wheat in the absence of celiac disease. Science Translational Medicine, 8(369), 369ra176.
• Vojdani, A. (2015). Cross-reactivity between gliadin and other dietary proteins and peptides. Clinical Reviews in Allergy & Immunology, 50(2), 1–12.

SEO tags: celiac disease, non-celiac gluten sensitivity, zonulin, leaky gut, tissue transglutaminase IgA, gluten-free diet, dermatitis herpetiformis, amylase-trypsin inhibitors, fructans, functional medicine, integrative chiropractic care, internal medicine oversight, El Paso Injury Medical Clinic, Dr. Maria Guadalupe Cardenas MD, Dr. Alexander Jimenez DC, autonomic nervous system, vagal tone, microbiome, malabsorption, osteoporosis, neuropathy, cardiovascular risk, rehabilitation, personal injury care